Welcome to our dedicated page for Cadre Hldgs SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cadre Holdings, Inc. (NYSE: CDRE) SEC filings page on Stock Titan provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. As a Delaware corporation listed on the New York Stock Exchange under the symbol CDRE, Cadre submits current reports on Form 8‑K, annual and quarterly reports, and other documents that describe its operations in safety and survivability equipment for law enforcement, first responder, military and nuclear markets.
In its Form 8‑K filings, Cadre reports material events such as quarterly financial results, investor presentations and significant transactions. For example, the company has filed 8‑Ks to furnish earnings press releases and slide presentations, and to disclose a securities purchase agreement to acquire TYR Tactical, a manufacturer of tactical gear and equipment for military, law enforcement and government agencies worldwide. These filings also confirm details such as Cadre’s incorporation in Delaware and its CDRE listing on the New York Stock Exchange.
Through its SEC reports, Cadre discusses non‑GAAP financial measures including EBITDA, adjusted EBITDA and adjusted EBITDA margin, explaining how these metrics relate to its GAAP results. Filings may also describe contract awards, like blast exposure monitoring programs handled by its Med‑Eng subsidiary, and provide additional context on acquisitions in nuclear safety and tactical equipment.
On Stock Titan, investors can review Cadre’s SEC filings alongside AI‑powered summaries that clarify key points in lengthy documents. Real‑time updates from EDGAR help users track new 8‑Ks, 10‑Qs and 10‑Ks as they are filed, while insider and governance‑related disclosures can be used to analyze management decisions and capital allocation. This page is a resource for understanding how Cadre communicates its financial performance, strategic transactions and risk factors through its regulatory filings.
Cadre Holdings, Inc. president Brad Williams received new equity awards as part of his compensation. He was granted 18,399 restricted stock units tied to Cadre common stock, which will vest in three equal installments of 6,133 shares on March 30 of 2027, 2028, and 2029.
Williams also received stock options for 59,597 shares at an exercise price of $29.39 per share, expiring on March 30, 2036. These options vest in three tranches: 19,867 shares on March 30, 2027, and 19,865 shares on each of March 30, 2028 and 2029.
Cadre Holdings, Inc. granted CEO and Chairman Warren B. Kanders new equity awards as part of his compensation. He received 44,684 restricted stock units tied to the company’s common stock.
According to the award terms, 14,896 RSUs will vest on March 30, 2027, and 14,894 RSUs will vest on each of March 30, 2028, and March 30, 2029. He was also granted options on 144,735 shares at a $29.39 exercise price, which vest in three equal installments on March 30 of 2027, 2028, and 2029 and expire on March 30, 2036.
Cadre Holdings, Inc. granted equity awards to its Chief Financial Officer, Blaine Browers. He received 15,333 restricted stock units tied to Cadre common stock, which will vest in three equal installments of 5,111 shares on March 30 of 2027, 2028, and 2029. He was also granted stock options for 49,664 shares at an exercise price of $29.39 per share, expiring on March 30, 2036, with one-third becoming exercisable on each of March 30, 2027, 2028, and 2029. These awards are part of the company’s 2021 Stock Incentive Plan and represent compensation, not open-market buying or selling.
Cadre Holdings, Inc. registers 7,500,000 shares of Common Stock on an acquisition shelf to be issued from time to time in connection with acquisitions. The prospectus states the shares may be issued as consideration alone or together with cash, notes, assumption of liabilities or other consideration.
The registration is an "acquisition shelf" prospectus supplement framework: shares will generally be valued at prices reasonably related to market prices when agreements are reached or when shares are delivered. The company will not receive cash proceeds from resales by selling securityholders; proceeds to the company are limited to the value of assets or businesses acquired in transactions where shares are issued.
Cadre Holdings, Inc. director, CEO and chairman Warren B. Kanders reported open-market sales of Common Stock through an affiliated entity. Kanders SAF, LLC sold 100,000 shares on March 20 at a weighted average price of $31.40 per share and another 100,000 shares on March 23 at a weighted average price of $31.93 per share, each executed across multiple trades within stated price ranges. After these sales, Kanders SAF, LLC held 9,917,039 shares, while Warren B. Kanders also reported 22,888 shares held directly, 1,305,650 shares held through his Roth IRA and 23,450 shares held through his spouse’s Roth IRA, and he disclaimed beneficial ownership beyond his pecuniary interest in these securities.
CDRE reports a Form 144 notice to sell 200,000 shares of Common Stock. The sale is listed with Merrill Lynch on the NYSE and shows an execution date of 03/20/2026. The filing also references a liquidating distribution tied to Kanders SAF LLC's pro rata membership interest in Maui Holdings LLC dated 12/07/2021.
Cadre Holdings president Brad Williams exercised vested equity awards and had shares withheld for taxes. On March 18, 2026, 4,508 restricted stock units from a 2024 grant converted into 4,508 shares of common stock at a $0.00 exercise price. To cover tax obligations from this vesting, 1,098 common shares were withheld by the company at $32.22 per share, leaving Williams with 65,081 common shares held directly after the transactions. The original 2024 restricted stock unit award covered 13,524 shares of common stock, with 4,508 shares vesting on each of March 18, 2025 and March 18, 2026, and a remaining 4,508 scheduled to vest on March 18, 2027.
Cadre Holdings, Inc. chief financial officer Blaine Browers reported routine equity compensation activity. On March 18, 2026, 3,282 restricted stock units from a March 18, 2024 award vested into an equal number of shares of common stock. To cover tax withholding on this vesting, 1,292 shares of common stock were withheld by the company at a price of $32.22 per share rather than sold on the open market. After these transactions, Browers directly holds 69,653 shares of Cadre common stock. The underlying restricted stock unit award originally covered 9,846 shares and continues to vest in annual installments through March 18, 2027.
Cadre Holdings CEO Warren B. Kanders reported routine equity compensation activity. On March 18, 2026, 11,180 restricted stock units granted in 2024 converted into an equal number of Cadre Holdings common shares. To cover tax obligations from this vesting, 4,400 common shares were withheld by the company at a price of $32.22 per share.
Following these transactions, Kanders holds 22,888 shares of common stock directly. He also reports additional indirect holdings, including shares held by Kanders SAF, LLC and by Roth IRAs for himself and his spouse, while disclaiming beneficial ownership except to the extent of his pecuniary interest.
Cadre Holdings, Inc. president Brad Williams reported routine equity compensation activity tied to restricted stock units vesting on March 13, 2026. He exercised RSUs covering 4,191 and 5,170 shares of common stock, creating 9,361 new shares.
To cover tax obligations from these vestings, the issuer withheld 1,021 and 1,388 shares at a price of $31.65 per share, for a total of 2,409 shares withheld. After these exercises and tax-withholding dispositions, Williams directly owns 61,671 shares of Cadre Holdings common stock.